Permissive, in vitro replication of hepatitis B virus genotype E

Area of Science:

• Hepatology
• Virology
• Cell Biology

Background:

• Hepatitis B virus (HBV) infection remains a significant global health concern.
• Understanding the HBV life cycle is crucial for developing effective antiviral strategies.
• Genotype E of HBV (HBV/E) is prevalent in certain regions, necessitating specific research tools.

Purpose of the Study:

• To establish a stable cell line that supports the complete HBV life cycle.
• To create a model for studying HBV genotype E characteristics and replication.
• To facilitate the development of targeted therapeutics and diagnostics for HBV/E.

Main Methods:

• Transfection of HepG2 cells with a retroviral plasmid containing a 1.1-fold genomic construct of HBV/E.
• Selection and characterization of the resulting stable cell line, HepG2-HBVE6.
• Analysis of HBV DNA production, gene expression (pregenomic, preS1, preS2/S transcripts), and antigen shedding.

Main Results:

• The HepG2-HBVE6 cell line stably retains the integrated HBV/E genome.
• Episomal HBV DNA replication and transcription of key viral genes were confirmed.
• Hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg) were detected in cell culture supernatant.
• Structures resembling HBV subviral and Dane particles were observed.

Conclusions:

• The HepG2-HBVE6 cell line effectively recapitulates the HBV life cycle for genotype E.
• This cell line serves as a valuable in vitro model for HBV/E research.
• It can be utilized for evaluating antiviral drugs, vaccine efficacy, and for producing HBV/E-specific reagents.